- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Thyroid eye disease (TED)
- Meeting Date: July 2026
Teprotumumab – July 2026
- Powder for I.V. infusion 500 mg
Public Summary Documents
Last updated
13 November 2026
